Showing results (1631-1640 of 1,727) with videos related to

Sort By:
Pageof 173
Inflammatory Bowel Diseases|May 1, 2026
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trialAnita Afzali, Silvio Danese, Remo Panaccione, et al.
Journal of Crohn'S & Colitis|March 13, 2012
Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian studyKrupa Krishnaprasad, Jane M Andrews, Ian C Lawrance, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2011
1-((3S,4S)-4-amino-1-(4-substituted-1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetesKim M Andrews, David A Beebe, John W Benbow, et al.
Environmental Epidemiology (Philadelphia, Pa.)|August 29, 2025
Association of tailpipe-related and nontailpipe-related air pollution exposure with neuroimaging outcomesRyan M Andrews, Stephanie T Grady, Neelum T Aggarwal, et al.
Blood|August 25, 2017
Molecular synergy underlies the co-occurrence patterns and phenotype of <i>NPM1</i>-mutant acute myeloid leukemiaOliver M Dovey, Jonathan L Cooper, Annalisa Mupo, et al.
Nature Immunology|November 13, 2012
Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cellsDaniel M Andrews, Lucy C Sullivan, Nikola Baschuk, et al.
European Journal of Immunology|February 18, 2014
Mice deficient in heparanase exhibit impaired dendritic cell migration and reduced airway inflammationIvan K H Poon, Katharine J Goodall, Simon Phipps, et al.
Pageof 173